SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-23-000050
Filing Date
2023-05-09
Accepted
2023-05-09 16:03:50
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K goss-20230509.htm   iXBRL 8-K 40338
2 EX-99.1 goss-20230509xexx991.htm EX-99.1 49497
6 GRAPHIC gossamerbio-logoxreg.jpg GRAPHIC 150783
  Complete submission text file 0001728117-23-000050.txt   441273

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20230509.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20230509_lab.xml EX-101.LAB 23924
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20230509_pre.xml EX-101.PRE 12606
8 EXTRACTED XBRL INSTANCE DOCUMENT goss-20230509_htm.xml XML 10823
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 23901843
SIC: 2834 Pharmaceutical Preparations